A detailed history of Madison Park Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Madison Park Capital Advisors, LLC holds 563 shares of LLY stock, worth $476,765. This represents 0.37% of its overall portfolio holdings.

Number of Shares
563
Previous 560 0.54%
Holding current value
$476,765
Previous $507 Million 1.58%
% of portfolio
0.37%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $2,316 - $2,880
3 Added 0.54%
563 $499 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $15,947 - $19,998
22 Added 4.09%
560 $507 Million
Q1 2024

Apr 05, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 3.58%
538 $418 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $293,056 - $345,474
558 New
558 $325 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Madison Park Capital Advisors, LLC Portfolio

Follow Madison Park Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Park Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Park Capital Advisors, LLC with notifications on news.